🔎 Trials Near Me

Gara Jalqabaatti › Lymphoma Follicular › Tennessee › Nashville

Qorannoo klinikaalii Lymphoma Follicular Nashville, TN keessatti

Qorannoo 18 Lymphoma Follicular f Nashville fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • Tennessee Oncology, Pllc Nashville, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05006716

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
  • Sarah Cannon Research Institute - Pharmacy, Nashville
  • SCRI Oncology Partners, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT03460977

A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

Namoota walitti qabaa jiraSadarkaa 2/3
  • SCRI Oncology Partners ( Site 7000), Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07634471

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

Namoota walitti qabaa jiraSadarkaa 1/2
  • SCRI Oncology Partners ( Site 0100), Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07519772

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Namoota walitti qabaa jiraSadarkaa 1
  • SCRI Oncology Partners, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07101328

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Namoota walitti qabaa jiraSadarkaa 1
  • Sarah Cannon Research Institute, Nashville
  • Vanderbilt University Medical Center, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07226843

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Nashville
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06549595

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Namoota walitti qabaa jiraSadarkaa 2
  • Research Site, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06526793

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Namoota walitti qabaa jiraSadarkaa 3
  • Tennessee Oncology, Nashville
Umuriin 12 hanga 100 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06784752

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

Namoota walitti qabaa jiraSadarkaa 3
  • Vanderbilt University Medical Center, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06091254

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Namoota walitti qabaa jiraSadarkaa 1
  • Vanderbilt University/Ingram Cancer Center, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06860594

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Namoota walitti qabaa jiraSadarkaa 3
  • Vanderbilt-Ingram Cancer Center, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT05303519

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 1/2
  • Vanderbilt University Medical Center, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05826535

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Namoota walitti qabaa jiraSadarkaa 2
  • Vanderbilt University Medical Center, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT06651177

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Namoota walitti qabaa jiraSadarkaa 1/2
  • TriStar BMT, Nashville
Umuriin 13 hanga 90 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06533579

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
  • Tennessee Oncology, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT07121946

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Tennessee Oncology, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Bit-2026 · NCT04830137

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Nashville
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Qorannoo Lymphoma Follicular magaalota biroo keessatti

Qorannoo biroo Nashville keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.